|
1
|
Sakaguchi S, Sakaguchi N, Asano M, Itoh M
and Toda M: Immunologic self-tolerance maintained by activated T
cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a
single mechanism of self-tolerance causes various autoimmune
diseases. J Immuno. 155:1151–1164. 1995.
|
|
2
|
Liu JY, Zhang XS, Ding Y, Peng RQ, Cheng
X, Zhang NH, Xia JC and Zeng YX: The changes of CD4+CD25+/CD4+
proportion in spleen of tumor-bearing BALB/c mice. J Transl Med.
3:52005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanamori M, Nakatsukasa H, Okada M, Lu Q
and Yoshimura A: Induced regulatory T cells: Their development,
stability, and applications. Trends Immunol. 37:803–811. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shevach EM and Thornton AM: tTregs,
pTregs, and iTregs: Similarities and differences. Immunol Rev.
259:88–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wainwright DA, Dey M, Chang A and Lesniak
MS: Targeting tregs in malignant brain cancer: Overcoming IDO.
Front Immunol. 4:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Danikowski KM, Jayaraman S and Prabhakar
BS: Regulatory T cells in multiple sclerosis and myasthenia gravis.
J Neuroinflammation. 14:1172017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Someya K, Nakatsukasa H, Ito M, Kondo T,
Tateda KI, Akanuma T, Koya I, Sanosaka T, Kohyama J, Tsukada YI, et
al: Improvement of Foxp3 stability through CNS2 demethylation by
TET enzyme induction and activation. Int Immunol. 29:365–375. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu J, Lu L, Chen M, Xu L, Lan Q, Li Q, Liu
Z, Chen G, Wang P, Wang X, et al: TGF-β-induced CD4+Foxp3+ T cells
attenuate acute graft-versus-host disease by suppressing expansion
and killing of effector CD8+ cells. J Immunol. 193:3388–3397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Namdari H, Ghayedi M, Hadjati J, Rezaei F,
Kalantar K, Rahimzadeh P and Salehi E: Effect of MicroRNA-21
transfection on in-vitro differentiation of human naive CD4+ T
cells to regulatory t cells. Iran J Allergy Asthma Immunol.
16:235–244. 2017.PubMed/NCBI
|
|
10
|
Jeker LT, Zhou X, Gershberg K, de
Kouchkovsky D, Morar MM, Stadthagen G, Lund AH and Bluestone JA:
MicroRNA 10a marks regulatory T cells. PLoS One. 7:e366842012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spoerl D, Duroux-Richard I, Louis-Plence P
and Jorgensen C: The role of miR-155 in regulatory T cells and
rheumatoid arthritis. Clin Immunol. 148:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang HY, Barbi J, Wu CY, Zheng Y, Vignali
PD, Wu X, Tao JH, Park BV, Bandara S, Novack L, et al: MicroRNA-17
modulates regulatory T cell function by Targeting Co-regulators of
the Foxp3 transcription factor. Immunity. 45:83–93. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin A, Wen Z, Zhou Y, Li Y, Li Y, Luo J,
Ren T and Xu L: MicroRNA-126 regulates the induction and function
of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway. J
Cell Mol Med. 17:252–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Zou J, Zheng G and Chu J: MiR-30a
decreases multidrug resistance (MDR) of gastric cancer cells. Med
Sci Monit. 0:02016.PubMed/NCBI
|
|
15
|
Li Y, Zhang J, Liu Y, Zhang B, Zhong F,
Wang S and Fang Z: MiR-30a-5p confers cisplatin resistance by
regulating IGF1R expression in melanoma cells. BMC Cancer.
18:4042018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park YR, Kim SL, Lee MR, Seo SY, Lee JH,
Kim SH, Kim IH, Lee SO, Lee ST and Kim SW: MicroRNA-30a-5p
(miR-30a) regulates cell motility and EMT by directly targeting
oncogenic TM4SF1 in colorectal cancer. J Cancer Res Clin Oncol.
143:1915–1927. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao B, Shi X and Bai J: miR-30a regulates
the proliferation and invasion of breast cancer cells by targeting
Snail. Oncol Lett. 17:406–413. 2019.PubMed/NCBI
|
|
18
|
Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui
B, Li Y, Song L and Gao Y: miR-30a radiosensitizes non-small cell
lung cancer by targeting ATF1 that is involved in the
phosphorylation of ATM. Oncol Rep. 37:1980–1988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang X, Xu C, Lei F, Liao M, Wang W, Xu
N, Zhang Y and Xie W: MiR-30a targets IL-1α and regulates islet
functions as an inflammation buffer and response factor. Sci Rep.
7:52702017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu E, Ding L, Miao H, Liu F, Liu D, Dou H
and Hou Y: MiR-30a attenuates immunosuppressive functions of
IL-1β-elicited mesenchymal stem cells via targeting TAB3. FEBS
Lett. 589:3899–3907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riess M, Fuchs NV, Idica A, Hamdorf M,
Flory E, Pedersen IM and König R: Interferons induce expression of
SAMHD1 in Monocytes through down-regulation of miR-181a and
miR-30a. J Biol Chem. 292:264–277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Sun Q and Dai L: Immune regulation
of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88
signaling pathway in THP-1 cells. Exp Ther Med. 14:3299–3303. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fang X, Sun D, Wang Z, Yu Z, Liu W, Pu Y,
Wang D, Huang A, Liu M, Xiang Z, et al: MiR-30a positively
regulates the inflammatory response of microglia in experimental
autoimmune Encephalomyelitis. Neurosci Bull. 33:603–615. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu X, Zhou J, Wang T, Han J, Ma L, Yu H,
Geng D, Fan H, Zhang Q, Hua F, et al: MiR-30a inhibits Th17
differentiation and demyelination of EAE mice by targeting the
IL-21R. Brain Behav Immun. 57:193–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cruz LO, Hashemifar SS, Wu CJ, Cho S,
Nguyen DT, Lin LL, Khan AA and Lu LF: Excessive expression of
miR-27 impairs Treg-mediated immunological tolerance. J Clin
Invest. 127:530–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ripamonti A, Provasi E, Lorenzo M, De
Simone M, Ranzani V, Vangelisti S, Curti S, Bonnal RJP, Pignataro
L, Torretta S, et al: Repression of miR-31 by BCL6 stabilizes the
helper function of human follicular helper T cells. Proc Natl Acad
Sci USA. 114:12797–12802. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takahashi R, Nakatsukasa H, Shiozawa S and
Yoshimura A: SOCS1 is a key molecule that prevents regulatory T
cell plasticity under inflammatory conditions. J Immunol.
199:149–158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi R and Yoshimura A: SOCS1 and
regulation of regulatory T cells plasticity. J Immunol Res.
2014:9431492014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Melnik BC, John SM, Carrera-Bastos P and
Schmitz G: Milk: A postnatal imprinting system stabilizing FoxP3
expression and regulatory T cell differentiation. Clin Transl
Allergy. 6:182016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao J, Li Y, Hu Y, Chen C, Zhou Y, Tao Y,
Guo M, Qin N and Xu L: MicroRNAs expression profile in CCR6(+)
regulatory T cells. PeerJ. 2:e5752014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mohammadnia-Afrouzi M, Hosseini AZ,
Khalili A, Abediankenari S, Amari A, Aghili B and Nataj HH: Altered
microRNA expression and immunosuppressive cytokine production by
regulatory T cells of ulcerative colitis patients. Immunol Invest.
45:63–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu Y, Wang C, Li Y, Zhao J, Chen C, Zhou
Y, Tao Y, Guo M, Qin N, Ren T, et al: MiR-21 controls in situ
expansion of CCR6+ regulatory T cells through PTEN/AKT pathway in
breast cancer. Immunol Cell Biol. 93:753–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sánchez-Díaz R, Blanco-Dominguez R,
Lasarte S, Tsilingiri K, Martín-Gayo E, Linillos-Pradillo B, de la
Fuente H, Sánchez-Madrid F, Nakagawa R, Toribio ML, et al:
Thymus-derived regulatory T cell development is regulated by C-Type
Lectin-mediated BIC/MicroRNA 155 expression. Mol Cell Biol.
37(pii): e00341–16. 2017.PubMed/NCBI
|
|
36
|
Bronevetsky Y, Burt TD and McCune JM:
Lin28b regulates fetal regulatory T cell differentiation through
modulation of TGF-β signaling. J Immunol. 197:4344–4350. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou Q, Haupt S, Kreuzer JT, Hammitzsch A,
Proft F, Neumann C, Leipe J, Witt M, Schulze-Koops H and Skapenko
A: Decreased expression of miR-146a and miR-155 contributes to an
abnormal Treg phenotype in patients with rheumatoid arthritis. Ann
Rheum Dis. 74:1265–1274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X
and Liao YH: MicroRNA-155 modulates Treg and Th17 cells
differentiation and Th17 cell function by targeting SOCS1. PLoS
One. 7:e460822012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu L, Xu W, Jiang Z, Zhang F, Chu Y and
Xiong S: Depletion of CD4(+)CD25(high) regulatory T cells from
tumor infiltrating lymphocytes predominantly induces Th1 type
immune response in vivo which inhibits tumor growth in adoptive
immunotherapy. Cancer Biol Ther. 8:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ilangumaran S, Bobbala D and Ramanathan S:
SOCS1: Regulator of T cells in autoimmunity and cancer. Curr Top
Microbiol Immunol. 410:159–189. 2017.PubMed/NCBI
|
|
41
|
Zhao M, Sun D, Guan Y, Wang Z, Sang D, Liu
M, Pu Y, Fang X, Wang D, Huang A, et al: Disulfiram and
Diphenhydramine Hydrochloride upregulate miR-30a to suppress
IL-17-associated autoimmune inflammation. J Neurosci. 36:9253–9266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sugase T, Takahashi T, Serada S, Fujimoto
M, Ohkawara T, Hiramatsu K, Nishida T, Hirota S, Saito Y, Tanaka K,
et al: SOCS1 gene therapy has antitumor effects in
imatinib-resistant gastrointestinal stromal tumor cells through
FAK/PI3K signaling. Gastric Cancer Nov. 21:968–976. 2018.
View Article : Google Scholar
|
|
43
|
Wang H, Wang J and Xia Y: Defective
suppressor of cytokine signaling 1 signaling contributes to the
pathogenesis of systemic lupus erythematosus. Front Immunol.
8:12922017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Knosp CA, Schiering C, Spence S, Carroll
HP, Nel HJ, Osbourn M, Jackson R, Lyubomska O, Malissen B, Ingram
R, et al: Regulation of Foxp3+ inducible regulatory T cell
stability by SOCS2. J Immunol. 190:3235–3245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu CR, Kim SH, Mahdi RM and Egwuagu CE:
SOCS3 deletion in T lymphocytes suppresses development of chronic
ocular inflammation via upregulation of CTLA-4 and expansion of
regulatory T cells. J Immunol. 191:5036–5043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kitz A, de Marcken M, Gautron AS, Mitrovic
M, Hafler DA and Dominguez-Villar M: AKT isoforms modulate Th1-like
Treg generation and function in human autoimmune disease. EMBO Rep.
17:1169–1183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kurebayashi Y, Baba Y, Minowa A, Nadya NA,
Azuma M, Yoshimura A, Koyasu S and Nagai S: TGF-β-induced
phosphorylation of Akt and Foxo transcription factors negatively
regulates induced regulatory T cell differentiation. Biochem
Biophys Res Commun. 480:114–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
